NEU 5.98% $20.20 neuren pharmaceuticals limited

So to me it sounds like the Bakers aren't impressed enough with...

  1. 390 Posts.
    lightbulb Created with Sketch. 202
    So to me it sounds like the Bakers aren't impressed enough with anything Acadia is doing right now to put up billions of dollars. Whilst that sounds negative the Bakers have to be looking at it with all the risks involved so what that says about Neuren is likely pretty minimal. As an Neu holder the main thing I want to see from Acadia short term is hitting their Q1 guidance and everything looking good for meeting their annual numbers because of a decent bounce back expected in Q2. So far Steve Davis has only talked about a solid rebound in February to almost previous growth levels. Encouraging but in no way definitive. If they know things aren't great now then I would have hoped they update quickly so I'm taking no news as good news so far. Anyone who holds Avita like me knows the market doesn't take well to guidance downgrades.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.20
Change
1.140(5.98%)
Mkt cap ! $2.579B
Open High Low Value Volume
$19.58 $20.52 $19.47 $9.631M 477.6K

Buyers (Bids)

No. Vol. Price($)
1 181 $20.19
 

Sellers (Offers)

Price($) Vol. No.
$20.24 245 1
View Market Depth
Last trade - 16.10pm 14/05/2024 (20 minute delay) ?
Last
$20.21
  Change
1.140 ( 5.70 %)
Open High Low Volume
$19.56 $20.51 $19.53 123739
Last updated 15.59pm 14/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.